Press releases | WebDisclosure

Basculer en Français

9567	Companies
189162	Keywords
120861	Articles
100933	Press releases

Home
Press releases

REGULATED PRESS RELEASE

published on 09/26/2025 at 07:30, 2 months 26 days ago

Gimv and EGS Beteiligungen reinforce strategic support for Spineart with CHF 25 million capital increase to accelerate global growth
Gimv and EGS Beteiligungen invest CHF 25 million in Spineart to boost global growth in advanced spine surgery solutions

Gimv Global Growth EGS Beteiligungen Spineart CHF 25 Million
PRESS RELEASE

published on 09/26/2025 at 07:30, 2 months 26 days ago

Informations privilégiées / Autres communiqués
Hoffmann Green annonce le vif succès de son augmentation de capital d'environ 7,9 M€ pour accélérer son développement commercial et industriel

Augmentation De Capital Décarbonation Développement Commercial Succès Hoffmann Green
PRESS RELEASE

published on 09/26/2025 at 07:30, 2 months 26 days ago

Inside Information / Other news releases
Hoffmann Green Cement announces successful €7.9 million capital increase for commercial and industrial growth. New shares issued at €4.50 unit price. Settlement on September 30, 2025

Capital Increase New Shares Commercial Development Hoffmann Green Cement Industrial Growth
PRESS RELEASE

published on 09/26/2025 at 07:00, 2 months 26 days ago

OSE Immunotherapeutics, Inserm Transfert et Nantes Université annoncent un partenariat stratégique pour accélérer l’innovation en immunothérapie
Partenariat stratégique entre OSE Immunotherapeutics, Inserm Transfert et Nantes Université pour accélérer l'innovation en immunothérapie. Objectif : transformer découvertes académiques en thérapies de rupture

Partenariat Immunothérapie OSE Immunotherapeutics Inserm Transfert Nantes Université
PRESS RELEASE

published on 09/26/2025 at 07:00, 2 months 26 days ago

OSE Immunotherapeutics, Inserm Transfert and Nantes University Announce Strategic Partnership to Accelerate Innovation in Immunotherapy
OSE Immunotherapeutics, Inserm Transfert, and Nantes University form a strategic partnership to advance immunotherapy for oncology, inflammation, and autoimmunity. The collaboration combines academic research and industrial expertise

Innovation Partnership Oncology Collaboration Immunotherapy
PRESS RELEASE

published on 09/26/2025 at 06:30, 2 months 26 days ago

Change in the Chairmanship of the Board of Directors
Change in the Chairmanship of the Board of Directors at Siegfried AG as Dr. Andreas Casutt steps down, proposing Dr. Beat Walti as the new Chairman. Siegfried Holding AG continues its successful growth journey

Board Of Directors Chairmanship Siegfried AG Dr. Andreas Casutt Dr. Beat Walti
PRESS RELEASE

published on 09/26/2025 at 06:12, 2 months 26 days ago

Ad hoc-annoucement pursuant to Art. 53 LR
Adval Tech Management AG releases ad hoc announcement pursuant to Art. 53 LR. For more information, visit www.advaltech.com

Ad Hoc Announcement SIX Swiss Exchange EQS News Adval Tech Management AG Art. 53 LR
PRESS RELEASE

published on 09/26/2025 at 05:15, 2 months 26 days ago

NioCorp Announces Commencement of Proposed Public Offering of Common Shares
NioCorp commences public offering in the United States via Maxim Group LLC for its Elk Creek Project, aiming to raise capital for construction and operations

Elk Creek Project NioCorp Maxim Group LLC Public Offering Capital Raising
PRESS RELEASE

published on 09/26/2025 at 02:01, 2 months 26 days ago

Wellgistics Health Announces Pricing of $5 Million Public Offering
Wellgistics Health, Inc. (NASDAQ: WGRX) announces pricing of public offering of 7,142,862 shares of common stock at $0.70 per share. Gross proceeds expected to be $5 million. Offering by H.C. Wainwright & Co

Public Offering H.C. Wainwright & Co. Pharmaceutical Distribution Wellgistics Health WGRX
PRESS RELEASE

published on 09/25/2025 at 23:30, 2 months 26 days ago

EssilorLuxottica: Essilor Stellest is the first and only FDA market authorized spectacle lens in the United States
EssilorLuxottica's Essilor Stellest lens, the first FDA market authorized spectacle lens in the U.S., clinically proven to slow myopia progression in children, with 71% effectiveness over 2 years

Clinical Data EssilorLuxottica FDA Market Authorization Spectacle Lens Myopia Progression

Accesswire

Published on 12/22/2025 at 22:50, 17 minutes ago

American Critical Minerals Clarifies Technical Disclosure
Published on 12/22/2025 at 22:35, 32 minutes ago

NioCorp to Begin Construction of Mine Portal at Its Elk Creek Critical Minerals Project
Published on 12/22/2025 at 22:02, 1 hour 5 minutes ago

Unusual Machines Receives Initial Order from Performance Drone Works for $3.75 Million as Part of a Strategic Supplier Relationship
Published on 12/22/2025 at 15:00, 8 hours 7 minutes ago

World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares
Published on 12/22/2025 at 14:40, 8 hours 27 minutes ago

Namibia Critical Metals Inc. Receives Proceeds of $1,154,762 from Exercise of Warrants

View all ACCESSWIRE

EQS Group

Published on 12/22/2025 at 22:05, 1 hour 2 minutes ago

mAbxience and Amneal Announces FDA Approval of Denosumab Biosimilars Referencing Prolia® and XGEVA®
Published on 12/22/2025 at 21:36, 1 hour 31 minutes ago

Revolution Wind and Sunrise Wind receive lease suspension orders from US Department of the Interior’s Bureau of Ocean Energy Management
Published on 12/22/2025 at 20:16, 2 hours 51 minutes ago

EQS-Adhoc: PIERER Mobility AG (to be renamed soon to Bajaj Mobility AG): CEO Gottfried Neumeister confirmed until the end of 2028
Published on 12/22/2025 at 20:10, 2 hours 57 minutes ago

POS-Transaction in Own Shares
Published on 12/22/2025 at 19:31, 3 hours 36 minutes ago

EQS-Adhoc: Marley Spoon Group SE: CEO Daniel Raab Re-appointed and Contract to be Extended until June 2029

Les Echos

Published on 12/22/2025 at 18:33, 4 hours 34 minutes ago

ABEO SE RENFORCE ET OBTIENT UNE TRÈS LARGE MAJORITÉ DU CAPITAL DE VOGO AVEC 90,84% DÉTENUS À L’ISSUE DE L’OFFRE RÉOUVERTE
Published on 12/22/2025 at 18:05, 5 hours 2 minutes ago

Covivio - Treasury shares transactions between December 15th , 2025 and December 19th, 2025
Published on 12/22/2025 at 18:05, 5 hours 2 minutes ago

Covivio - Déclaration des transactions sur actions propres réalisées du 15 décembre au 19 décembre 2025
Published on 12/22/2025 at 17:45, 5 hours 22 minutes ago

Déclaration des transactions sur actions propres réalisées du 15 au 19 décembre 2025 dans le cadre du programme de rachat d’actions
Published on 12/22/2025 at 17:35, 5 hours 32 minutes ago

DECLARATION HEBDOMADAIRE D'OPERATIONS EFFECTUEES DU 15 AU 19 DECEMBRE 2025

View all LES ECHOS COMFI WIRE